Cencora Stock Today

COR Stock  USD 227.64  2.18  0.95%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
Cencora is selling at 227.64 as of the 17th of December 2024; that is 0.95% down since the beginning of the trading day. The stock's lowest day price was 225.78. Cencora has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on November 14, 2024, Representative Michael McCaul of US Congress acquired $15k to $50k worth of Cencora's common stock.
Business Domain
Health Care Equipment & Services
IPO Date
4th of April 1995
Category
Healthcare
Classification
Health Care
CoreSite Realty Corporation delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. Our scalable, flexible solutions and 460 dedicated employees consistently deliver unmatched data center options all of which leads to a best-in-class customer experience and lasting relationships. The company has 193.28 M outstanding shares of which 10.11 M shares are currently shorted by investors with about 7.92 days to cover. More on Cencora

Moving together with Cencora Stock

  0.69GH Guardant HealthPairCorr
  0.85LH LaboratoryPairCorr
  0.78MD Mednax IncPairCorr

Moving against Cencora Stock

  0.67DRIO DarioHealth CorpPairCorr
  0.58VERO Venus ConceptPairCorr
  0.35EDAP EDAP TMS SAPairCorr

Cencora Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO, PresidentPharmD Mauch
Thematic IdeaWholesale (View all Themes)
Old Names[CONWERT IMMOBIL INV, Conwert Immobilien Invest Se, CONWERT IMMOBIL INV - Dusseldorf Stock Exchang, CONWERT IMMOBIL INV (COR.SG), Conwert Immobilien Invest SE, Zortrax S.A.]
Business ConcentrationHealth Care Providers & Services, Health Care Equipment & Services, Health Care, PSI 20 Stock, NYSE Composite, SP 500 Index, PSI All Share, Nasdaq Benchmark Consumer, Wholesale, Health Care, Health Care Providers & Services, REIT—Specialty, Real Estate (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover5.174.3808
Fairly Up
Slightly volatile
Gross Profit Margin0.04080.0337
Fairly Up
Very volatile
Total Current Liabilities57 B54.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total12.6 B12 B
Sufficiently Up
Slightly volatile
Total Assets70.5 B67.1 B
Sufficiently Up
Slightly volatile
Total Current Assets50.1 B47.7 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities3.7 B3.5 B
Sufficiently Up
Slightly volatile
Debt Levels
Cencora can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cencora's financial leverage. It provides some insight into what part of Cencora's total assets is financed by creditors.
Liquidity
Cencora has 4.39 B in debt. Cencora has a current ratio of 0.57, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Cencora to invest in growth at high rates of return.

Depreciation

1.17 Billion
Cencora (COR) is traded on New York Stock Exchange in USA. It is located in 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 and employs 46,000 people. Cencora is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 44.89 B. Cencora runs under Health Care Providers & Services sector within Health Care industry. The entity has 193.28 M outstanding shares of which 10.11 M shares are currently shorted by investors with about 7.92 days to cover. Cencora has about 2.59 B in cash with 3.48 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08.
Check Cencora Probability Of Bankruptcy
Ownership Allocation
Cencora holds a total of 193.28 Million outstanding shares. The majority of Cencora outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cencora to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cencora. Please pay attention to any change in the institutional holdings of Cencora as this could imply that something significant has changed or is about to change at the company. Also note that nearly eight million four hundred eighty-four thousand nine hundred ninety-two invesors are currently shorting Cencora expressing very little confidence in its future performance.
Check Cencora Ownership Details

Cencora Stock Institutional Holders

InstituionRecorded OnShares
Morgan Stanley - Brokerage Accounts2024-09-30
2.9 M
Capital Research Global Investors2024-09-30
2.9 M
Amvescap Plc.2024-09-30
2.7 M
Bessemer Group Inc2024-09-30
2.2 M
Northern Trust Corp2024-09-30
2.2 M
Pacer Advisors, Inc.2024-09-30
2.1 M
Legal & General Group Plc2024-09-30
1.8 M
Two Sigma Advisers, Llc2024-09-30
1.6 M
Norges Bank2024-06-30
1.6 M
Vanguard Group Inc2024-09-30
21.3 M
Walgreens Boots Alliance Inc2024-09-30
20 M
View Cencora Diagnostics

Cencora Historical Income Statement

At this time, Cencora's EBITDA is relatively stable compared to the past year. As of 12/17/2024, Cost Of Revenue is likely to grow to about 298.3 B, while Interest Expense is likely to drop slightly above 88.6 M. View More Fundamentals

Cencora Stock Against Markets

Cencora Corporate Directors

David WilsonLead Independent DirectorProfile
James AttwoodIndependent DirectorProfile
John ThompsonIndependent DirectorProfile
Jean BuaIndependent DirectorProfile

Additional Tools for Cencora Stock Analysis

When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.